[1] Siegel R,Ma J,Zou Z,et al.Cancer statistics[J].CA Cancer J Clin,2014,64(1):9-29.
[2] 韩苏军,张思维,陈万青,等.中国膀胱癌发病现状及流行趋势分析[J].癌症进展,2013,11(1):89-95.
[3] Babjuk M,Burger M,Zigeuner R,et al.EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder:update 2013[J].Eur Urol,2013,64(4):639-653.
[4] van Rhijn BW,Burger M,Lotan Y,et al.Recurrence and progression of disease in non-muscle- invasive bladder cancer:from epidemiology to treatment strategy[J].Eur Urol,2009,56(3):430-442.
[5] Yeung C,Dinh T,Lee J.The health economics of bladder cancer:an updated review of the published literature[J].Pharmacoeconomics,2014,32(11):1093-1104.
[6] Bartel DP.MicroRNAs:target recognition and regulatory functions[J].Cell,2009,136(2):215-233.
[7] 李文,胡喆,林智君,等.miR-137对Parkin诱导的线粒体自噬的影响[J].新医学,2015,46(5):283-288.
[8] 金向宇,洪卫.microRNA-34a在肺癌细胞凋亡中的作用[J].中华全科医学,2016,14(6):940-943.
[9] Bar-Eli M.Searching for the‘melano-miRs’:miR-214 drives melanoma metastasis[J].EMBO J, 2011,30(10):1880-1881.
[10] Schwarzenbach H,Milde-Langosch K,Steinbach B,et al.Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients[J].Breast Cancer Res Treat,2012,134(3): 933-941.
[11] Shih TC,Tien YJ,Wen CJ,et al.MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma[J].J Hepatol, 2012,57(3):584-591.
[12] Zhou Y,Hong L.Prediction value of miR-483 and miR-214 in prognosis and multidrug resistance of esophageal squamous cell carcinoma[J].Genet Test Mol Biomarkers,2013,17(6):470-474.
[13] Wang J,Zhang X,Wang L,et al.Downregulation of urinary cell-free microRNA-214 as a diagnostic and prognostic biomarker in bladder cancer[J].J Surg Oncol,2015,111(8):992-999.
[14] Zhang XJ,Ye H,Zeng CW,et al.Dysregulation of miR-15a and miR-214 in human pancreatic cancer[J].J Hematol Oncol,2010,3:46.
[15] Penna E,Orso F,Cimino D,et al.microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C[J].EMBO J,2011,30(10):1990-2007.
[16] 马明,金国江,付立业,等.上调microRNA-100对结肠癌HT-29细胞增殖和侵袭的影响[J].现代肿瘤医学,2016,24(7):1031-1033.
[17] Xu C,Zeng Q,Xu W,et al.miRNA-100 inhibits human bladder urothelial carcinogenesis by directly targeting mTOR[J].Mol Cancer Ther,2013,12(2):207-219.
[18] Banfai B,Jia H,Khatun J,et al.Long noncoding RNAs are rarely translated in two human cell lines[J].Genome Res,2012,22(9):1646-1657.
[19] Batista PJ,Chang HY.Long noncoding RNAs:cellular address codes in development and disease[J].Cell,2013,152(6):1298-1307.
[20] Hung T,Chang HY.Long noncoding RNA in genome regulation:prospects and mechanisms[J].RNA Biol,2010,7(5):582-585.
[21] Okazaki Y,Furuno M,Kasukawa T,et al.Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs[J].Nature,2002,420(6915):563-573.
[22] Ponting CP,Oliver PL,Reik W.Evolution and functions of long noncoding RNAs[J].Cell, 2009,136(4):629-641.
[23] Szymanski M,Barciszewska MZ,Erdmann VA,et al.A new fron-tier for molecular medicine: noncoding RNAs[J].Biochim Biophys Acta,2005,1756(1):65-75.
[24] Perez DS,Hoage TR,Pritchett JR,et al.Long,bundantly expressednon-coding transcripts are altered in cancer[J].Hum Mol Genet,2008,7(5):642-655.
[25] Louro R,Smirnova AS,Verjovski-Almeida S,et al.Long intronic noncod-ing RNA transcription: expression noise or expression choice?[J].Genomics,2009,93(4):291-298.
[26] Khalil AM, Guttman M, Huarte M, et al.Many human large inter-genicnoncoding RNAs associate with chromatin- modifying comple-xes and affect gene expression[J].Proc Natl Acad Sci USA, 2009,106(28):11667-11672.
[27] Morris KV,Santoso S,Turner AM,et al.Bidirectional transcription directs both transcriptional gene activation and suppression in human cells[J]. PLoS Genet,2008,4(11): e1000258.
[27] Chen T,Xie W,Xie L,et al.Expression of long noncoding RNA lncRNA-n336928 is correlated with tumor stage and grade and overall survival in bladder cancer[J].Biochem Biophys Res Commun,2015,468(4):666-670.
[28] Yu W,Gius D,Onyango P,et al.Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA[J].Nature,2008,451(7175):202-206.
[29] Guil S,Soler M,Portela A,et al.Intronic RNAs mediate EZH2 regulation of epigenetic targets[J].Nat Struct Mol Biol,2012,19(7):664-670.
[30] Zhu H,Li X,Song Y,et al.Long non-coding RNA ANRIL is up-regulated in bladder cancer and regulates bladder cancer cell proliferation and apoptosis through the intrinsic pathway[J]. Biochem Biophys Res Commun,2015,467(2):223-228.
[31] Choi JW,Herr DR,Noguchi K,et al.LPA receptors: subtypes and biological actions[J].Annu Rev Pharmacol Toxicol,2010,50(1):157-186.
[32] Parrill AL,Tigyi G.Integrating the puzzle pieces:the current atomistic picture of phospholipid-G protein coupled receptor interactions[J].Biochim Biophys Acta,2013,1831(1):2-12.
[33] Kihara Y,Maceyka M,Spiegel S,et al.Lysophospholipid receptor nomenclature review:IUPHAR Review 8[J].Br J Pharmacol,2014,171(15):3575-3594.
[34] Komachi M,Sato K,Tobo M,et al.Orally active lysophosphatidic acid receptor antagonist attenuates pancreatic cancer invasion and metastasis in vivo[J].Cancer Sci,2012,103(6):1099-1104.
[35] Kataoka M,Ishibashi K,Kumagai S,et al.Expression and function of LPA1 in bladder cancer[J]. J Urol,2015,194(1):238-244. |
